Resumption of menstrual regularity · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
Resumption of spontaneous ovulation · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
no estimate extracted
2011 participants
GRADE not reported
Clinician's assessment of improvement of hirsutism Ferriman‐Gallwey score Scale from: 0 to 36 · women with polycystic ovary syndrome not actively trying to conceive
1 finding from 1 review
Asthma exacerbations requiring hospitalisation or a course of steroids · people with asthma
The review found no eligible studies for this question.
1 finding from 1 review
Statins for asthma 2020 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · people with asthma
The review found no eligible studies for this question.
1 finding from 1 review
Statins for asthma 2020 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Change in morning PEF (L/min) at endpoint · people with asthma
It is very uncertain whether atorvastatin changes lung function: change in morning PEF compared with placebo (very low certainty).
1 finding from 1 review
Change from baseline in pre‐bronchodilator FEV1 · people with asthma
It is very uncertain whether atorvastatin changes lung function: change in FEV1 (pre) compared with placebo (very low certainty).
1 finding from 1 review
Lung function: change in FEV1 (post) · people with asthma
It is very uncertain whether atorvastatin changes lung function: change in FEV1 (post) compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events or adverse events · people with asthma
The review found no eligible studies for this question.
1 finding from 1 review
Statins for asthma 2020 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Asthma control · people with asthma
It is very uncertain whether atorvastatin changes asthma control: change in ACQ compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
Change in carotid intima‐media thickness (mm) ‐ at 2 years · children with familial hypercholesterolemia
1 finding from 1 review
Intervention not reported
Change in serum LDL cholesterol level (%) ‐ at end of · children with familial hypercholesterolemia
1 finding from 1 review
Intervention not reported
Change in measures of growth and maturation: change in puberty proportion with Tanner stage ≧ 1 level ‐ at 2 years · children with familial hypercholesterolemia
The intervention showed no clear difference in change in measures of growth and maturation: change in puberty… (low certainty).
1 finding from 1 review
Intervention not reported
Liver dysfunction: proportion with changed aspartate aminotransferase or alanine aminotransferase levels (> 3x ULN) ‐ at all time points · children with familial hypercholesterolemia
1 finding from 1 review
Intervention not reported
Myopathy: proportion with changed serum creatine kinase levels (>10x ULN) ‐ at all time points · children with familial hypercholesterolemia
1 finding from 1 review
Intervention not reported
Change in endothelial function: Change in flow‐mediated dilatation of brachial artery (%) · children with familial hypercholesterolemia
1 finding from 1 review
Intervention not reported
Adverse events ‐ at one year · children with familial hypercholesterolemia
The intervention showed no clear difference in adverse events ‐ at one year (moderate certainty).
1 finding from 1 review
Intervention not reported
Cardiovascular mortality · people with hyperlipidaemia
1 finding from 1 review
Intervention not reported
Cardiovacular morbidity · people with hyperlipidaemia
1 finding from 1 review
Intervention not reported
At least 1 adverse event · people with hyperlipidaemia
The intervention showed no clear difference in at least 1 adverse event (low certainty).
1 finding from 1 review